| GENE_SYMBOL |
HGNC_ID |
UNIPROT_ID |
DRUG_NAME |
PUBCHEM_CID |
Datasource |
| ADORA2B |
HGNC:264 |
P29275 |
US20230293517, Example 6.41 |
162688386 |
BindingDB |
| ADORA2B |
HGNC:264 |
P29275 |
US20230293517, Example 6.105 |
162688388 |
BindingDB |
| ADORA2B |
HGNC:264 |
P29275 |
US20230293517, Example 6.54 |
162688404 |
BindingDB |
| ADORA2B |
HGNC:264 |
P29275 |
US20230293517, Example 17 |
162688413 |
BindingDB |
| ADORA2B |
HGNC:264 |
P29275 |
US20230293517, Example 3.6 |
162688418 |
BindingDB |
| ADORA2B |
HGNC:264 |
P29275 |
US20230293517, Example 6.97 |
162688422 |
BindingDB |
| ADORA2B |
HGNC:264 |
P29275 |
US20230293517, Example 8 |
162688432 |
BindingDB |
| ADORA2B |
HGNC:264 |
P29275 |
US20230293517, Example 6.22 |
162688433 |
BindingDB |
| ADORA2B |
HGNC:264 |
P29275 |
US20230293517, Example 5.7 |
162688444 |
BindingDB |
| ADORA2B |
HGNC:264 |
P29275 |
US20230293517, Example 6.20 |
162688448 |
BindingDB |
| ADORA2B |
HGNC:264 |
P29275 |
US20230293517, Example 16.8 |
162688454 |
BindingDB |
| ADORA2B |
HGNC:264 |
P29275 |
US20230293517, Example 4.26 |
162688456 |
BindingDB |
| ADORA2B |
HGNC:264 |
P29275 |
US20230293517, Example 6.57 |
162688457 |
BindingDB |
| ADORA2B |
HGNC:264 |
P29275 |
US20230293517, Example 6.56 |
162688460 |
BindingDB |
| ADORA2B |
HGNC:264 |
P29275 |
US20230293517, Example 6.8 |
162688463 |
BindingDB |
| ADORA2B |
HGNC:264 |
P29275 |
US20230293517, Example 10 |
162688465 |
BindingDB |
| ADORA2B |
HGNC:264 |
P29275 |
US20230293517, Example 6.100 |
162688470 |
BindingDB |
| ADORA2B |
HGNC:264 |
P29275 |
N-(3-hydroxycyclobutyl)-2-[[(1S)-1-pyridin-2-ylethyl]amino]thieno[3,2-d]pyrimidine-4-carboxamide |
162779409 |
BindingDB |
| ADORA2B |
HGNC:264 |
P29275 |
2-[(5-fluoropyridin-3-yl)methylamino]-N-(pyrrolidin-2-ylmethyl)thieno[3,2-d]pyrimidine-4-carboxamide |
162779421 |
BindingDB |
| ADORA2B |
HGNC:264 |
P29275 |
2-[[(1S)-1-(5-chloropyridin-3-yl)ethyl]amino]-N-(3-hydroxycyclobutyl)thieno[3,2-d]pyrimidine-4-carboxamide |
162779426 |
BindingDB |